To Probe Full and Partial Activation of Human Peroxisome Proliferator-Activated Receptors by Pan-Agonist Chiglitazar Using Molecular Dynamics Simulations

Chiglitazar is a promising new-generation insulin sensitizer with low reverse effects for the treatment of type II diabetes mellitus (T2DM) and has shown activity as a nonselective pan-agonist to the human peroxisome proliferator-activated receptors (PPARs) (i.e., full activation of PPARγ and a part...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Holli-Joi, Wang, Xiaoyan, Nogle, Shaina, Liao, Siyan, Wu, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152983/
https://www.ncbi.nlm.nih.gov/pubmed/32308671
http://dx.doi.org/10.1155/2020/5314187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152983/
https://www.ncbi.nlm.nih.gov/pubmed/32308671
http://dx.doi.org/10.1155/2020/5314187

Ejemplares similares